Wells Fargo’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Wells Fargo’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,000	Closed	-$1K	–	6576
2017 Q3	$1K	Buy	+2,000	New	+$153K	﹤0.01%	6251

Wells Fargo's LUMO Position: Q4 2024 in Review

Wells Fargo sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 64,981 shares — an estimated $251K sold.

Wells Fargo first reported a position in LUMO in Q2 2013 and held it in 46 quarters. The position peaked at $5.39M in Q1 2015. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

Wells Fargo reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Wells Fargo sold 64,981 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $251K.
Wells Fargo first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 46 quarters.
Wells Fargo's Lumos Pharma, Inc. Common Stock position peaked at $5.39M in Q1 2015.
0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.